ENSG vs LLY
Ensign Group vs Eli Lilly and Company — AI-powered side-by-side comparison
VS
LLY
Eli Lilly and Company
68
Buy
| Metric | ENSG | LLY |
|---|
| AI Score |
68
|
68
|
| Price |
$181.61
|
$1,180.33
|
| P/E Ratio |
27.65×
|
39.54×
|
| ROE |
15.4%
|
77.8%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
14.1%
|
84.0%
|
| Debt / Equity |
0.92×
|
1.62×
|
| Dividend Yield |
0.1%
|
0.6%
|
| RSI (14) |
61.1
|
57.1
|
| Beta |
0.694
|
0.506
|
| Expected Upside |
+6.6%
|
+5.8%
|
AI Committee View
Current Innellis committee reasoning for ENSG versus LLY.
The committee scores are tied.
ENSG and LLY both score 68/100.
ENSG Committee View
83% agreement
6 analysts
The primary driver is low leverage (debt-to-equity 0.06) -- balance sheet can absorb a shock. The main limiting factor is p/e of 28.0 is moderate-to-rich. The committee is constructive but not yet at full conviction.
Bull Case
- ROE of 16.5% shows genuine earnings power backing the valuation — Value
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- P/E of 28.0 is moderate-to-rich — Value
- Price-to-book of 4.5x prices in significant intangible value — Value
LLY Committee View
75% agreement
4 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth